{"file_path": "/Users/sz904/Desktop/11711/LTI_Neural_Navigator/data/2024-02-26/chunk_paper_txt/Rita_Singh_A_Gene-Based_Algorithm_for_Identifying_Factors_That_May_Affect_a_Speaker\u2019s_Voice_chunk_14.txt", "num_qa_pairs": 10, "qa_list": [{"question": " What is the OMIM number for the Chromosome 17q21.31 deletion syndrome?,answer: OMIM: 610443", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What are the names associated with Chromosome 17q11.2?,answer: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, peripheral type; Morbus\u2013Recklinghausen", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What is the genomic coordinate for Chromosome 22q11.2?,answer: Genomic coordinates (GRCh38): 22:23,100,000\u201325,500,000", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What are some of the names associated with Chromosome 19q13.11 deletion syndrome?,answer: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " Which syndrome is associated with the OMIM number 613355?,answer: Chromosome 17q23.1\u2013q23.2 deletion syndrome", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What are some of the genes associated with the Chromosome 18q deletion syndrome?,answer: BCL2, SMAD4, ROCK1, SMAD2, ACAA2, NFATC1, PIK3C3, SMAD7, LAMA3, SLC14A2", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What is the Cytogenetic location for Chromosome Xp11.3 deletion syndrome?,answer: Cytogenetic location: Xp11.3", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What names are associated with Xq28 (a) syndrome?,answer: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What is the OMIM number for Rett syndrome?,answer: OMIM: 312750", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}, {"question": " What is the name for the Yq11 syndrome?,answer: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syndrome; germ cell aplasia, spermatogenic failure", "ref_chunk": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}], "doc_text": "GUCY2D, TP53, TRAPPC1, MPDU1, CDG1F, FXR2, FMRP, 27 of 33 Reported Effects on Speech Delayed or impaired speech Delayed speech Delayed speech [48] Apraxia, dysarthria, impaired or delayed speech [49] \u2013Not available\u2013 Delayed or impaired speech [50] Delayed speech; dysarthria [51] Absent speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes 17p13.3 OMIM: 247200; Cytogenetic location: 17p13.3 Genomic coordinates (GRCh38): 17:0\u20133,400,000 Names: Miller\u2013Dieker lissencephaly syndrome; MDLS; chromosome 17p13.3 deletion syndrome (included) {VN2}: CRK98 RPA186 YWHAE83 PAFAH1B134 INPP5K16 ABR12 SERPINF210 SLC43A29 OR3A18 OR1G18 (27 more . . .) SMYD41 SERPINF11 17q11.2 OMIM: 162200 Names: Neuro\ufb01bromatosis type I; NF1; Von Recklinghausen disease; neuro\ufb01bromatosis, periph- eral type; Morbus\u2013Recklinghausen {VN2}: SLC6A473 KSR166 NF162 NOS241 PSMD1130 VTN28 NLK27 CDK5R126 RPL23A22 ALDOC19 (30 more . . .) RAB11FIP41 MIR451A1 MIR4231 17q12 OMIM: 614527; Cytogenetic location: 17q12 Genomic coordinates (GRCh38): 17:33,500,000\u2013 39,800,000 Names: Chromosome 17q12 deletion syndrome {VN1} ERBB2124 {VN2}: CACNB1129 ERBB2124 AP2B149 PIP4K2B43 ACACA41 CCL530 CCL230 PSMB325 CCL424 RPL2323 (49 more . . .) PEX121 MMP281 DUSP141 17q21.31 OMIM: 610443 Names: Koolen\u2013De Vries syndrome; KDVS; chromosome 17q21.31 deletion syndrome; Microdele- tion 17q21.31 syndrome {VN1}: KANSL14 BRCA164 {VN2}: ITGA2B95 BRCA164 MAP3K1459 G6PC143 FZD238 WNT336 DUSP331 HDAC528 NSF27 AOC324 (36 more . . .) TMEM106A1 RND21 HEXIM11 17q23.1-q23.2 OMIM: 613355; Cytogenetic location: 17q23.1\u2013q23.2 Genomic coordinates (GRCh38): 17:59,500,000\u201363,100,000 Names: Chromosome 17q23.1\u2013q23.2 deletion syndrome {VN2}: RPS6KB191 CLTC54 BRIP124 MIR2119 SKA212 MRC212 PTRH27 CA47 MED135 DHX404 (5 more . . .) BCAS31 APPBP21 (Multiple incl. ABCA5, MAP2K6, SOX9) \u2020\u2021 17q24.3\u2013q24.2 OMIM: 135400; Cytogenetic location: 17q24.2\u2013q24.3 Genomic coordinates (GRCh38): 17:66,200,000\u2013 72,900,000 Names: Hypertrichosis, congenital generalized, with or without gingival hyperplasia; HTC3; \ufb01bromatosis, gingival, with hypertrichosis; chromosome 17q24.2\u2013q24.3 deletion syndrome {VN2}: PRKCA237 MAP2K6131 PRKAR1A122 KCNJ271 PSMD1231 CACNG421 KPNA216 KCNJ1613 (14 more . . .) BPTF1 Chromosome 18 deletions 18q OMIM: 601808; Cytogenetic location: 18q Genomic coordinates (GRCh38): 18:18,500,000\u2013 80,373,285 Names: Chromosome 18q deletion syndrome; 18q syndrome {VN2}: BCL2100 SMAD479 ROCK178 SMAD266 ACAA260 NFATC152 PIK3C343 SMAD736 LAMA335 SLC14A234 (112 more . . .) SS181 SETBP11 SERPINB41 SERPINB131 RIOK31 NETO11 MIR1221 MBD11 LINC-ROR1 GAREM11 CELF41 (Implicated Genes from Microarray Studies) (LIS1, PAFAH1B1, YWHAE) \u2020\u2021 (NF1)\u2021 (Multiple incl. HNF1B, LHX1, CCL3L3, SNIP) \u2020\u2021 (KANSL1, MAPT, CRHR1) \u2021 (TBX4) \u2020\u2021 (Multiple incl. MBP, TSHZ1) \u2020\u2021 28 of 33 Reported Effects on Speech Delayed speech [52] No signi\ufb01cant speech issues Delayed or impaired speech Delayed or absent speech Delayed speech [53] Delayed speech [54] Delayed [55] or impaired [56] speech Entropy 2023, 25, 897 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Chromosome 19 deletions 19p13.13 OMIM: 613638; Cytogenetic location: 19p13.13 Genomic coordinates (GRCh38): 19:12,600,000\u2013 13,800,000 Names: Chromosome 19p13.13 deletion syndrome {VN1} MAP2K2257 UHRF16 {VN2}: MAP2K2257 FGF22102 VAV1100 POLR2E85 SHC281 GNG775 PIP5K1C58 GTF2F153 GNA1148 PSPN47 (121 more . . .) ZBTB7A1 TJP31 SEMA6B1 REXO11 PLIN41 MYDGF1 MIR7-31 DPP91 DAZAP11 19q13.11 OMIM: 613026 (distal)/ 617219 (proximal); Cytogenetic location: 19q13.11 Genomic coordinates (GRCh38): 19:31,900,000\u201335,100,000 Names: Chromosome 19q13.11 deletion syndrome, distal; chromosome 19q13.11 deletion syndrome, proximal {VN1} CEBPA23 {VN2}: SCN1B62 GPI51 SLC7A939 PSMC428 CEBPA23 SLC7A1013 UBA28 CHST87 WTIP6 RGS9BP6 (12 more . . .) Chromosome 20 deletions 20p12.3 {VN2}: PLCB1159 PCNA79 PLCB468 BMP233 MCM825 PROKR29 CRLS19 CDS29 GPCPD18 RPS18P16 HAO16 TRMT63 LRRN41 Chromosome 22 deletions 22q11.2 OMIM: 611867; Cytogenetic location: 22q11.2 Genomic coordinates (GRCh38): 22:23,100,000\u2013 25,500,000 Names: Chromosome 22q11.2 deletion syndrome; distal chromosome 22q11.2 deletion syndrome {VN2}: MAPK1469 CRKL68 GGT162 BID56 ADORA2A35 COMT33 GNAZ32 UPB124 ATP6V1E123 IGL22 (56 more . . .) PIWIL31 MIR1851 22q12.2 OMIM: 101000 Names: Neuro\ufb01bromatosis type II; neuro\ufb01bromatosis, central type; acoustic schwannomas, bilat- eral; bilateral acoustic neuro\ufb01bromatosis; BANF; acoustic neurinoma, bilateral; ACN {VN2}: LIF26 PLA2G320 AP1B120 LIMK219 INPP5J18 OSM15 PISD14 SFI113 RNF18513 MTMR312 (17 more . . .) SEC14L21 PIK3IP11 MIR32001 DEPDC51 22q13.3 OMIM: 606232 Names: Phelan\u2013McDermid syndrome; PHMDS; chromosome 22q13.3 deletion syndrome; telom- eric 22q13 monosomy syndrome {VN1} BRD19 {VN2}: MAPK11140 MAPK1284 NUP5079 PRR538 PPARA35 WNT7B31 TYMP23 HDAC1019 CHKB19 ARSA19 (35 more . . .) UPK3A1 PLXNB21 GRAMD41 CELSR11 Chromosome X deletions Xp11.3 OMIM: 300578; Cytogenetic location: Xp11.3 Genomic coordinates (GRCh38): X:42,500,000\u2013 47,600,000 Names: Chromosome Xp11.3 deletion syndrome; mental retardation, X-linked, with retinitis pig- mentosa {VN1} KDM6A6 {VN2}: ARAF106 MAOA72 MAOB37 UBA118 TIMP116 NDUFB1110 MIR22110 CHST710 MIR2229 USP118 (10 more . . .) (Implicated Genes from Microarray Studies) (Multiple incl. NFIX, MAST1, CALR) \u2020\u2021 (Multiple incl. LSM14A, UBA2, WTIP, TSHZ3) \u2020\u2021 (Multiple incl. BMP2) (Multiple incl. TBX1 \u2020, COMT \u2020, INI1 \u2020\u2021, TOP3B \u2020\u2021 ) (NF2) \u2021 (ARSA, SHANK3) \u2021 (Multiple incl. RP2, ZNF674) \u2020\u2021 29 of 33 Reported Effects on Speech Delayed speech; impaired speech [57] Delayed or absent speech; impaired speech [58] Delayed or Impaired speech [59] Apraxia, dysarthria, delayed, or impaired speech [60] Delayed or impaired speech [61] Delayed or absent speech Impaired speech [62] Entropy 2023, 25, 897 30 of 33 Table A1. Cont. Syndrome Other Information Voice Chains and Their Member Chainlink Genes Xp21 OMIM: 300679; Cytogenetic location: Xp21 Genomic coordinates (GRCh38): X:31,500,000\u2013 37,800,000 Names: Chromosome Xp21 deletion syndrome; Complex glycerol kinase de\ufb01ciency {VN2}: TAB352 CYBB26 GK16 DMD12 NR0B18 XK5 ARX2 Xq28 (a) OMIM: 300475 Names: Deafness, dystonia, and cerebral hypomyelination; DDCH; contiguous ABCD1/DXS1375E deletion syndrome, included; CADDS, included {VN2}: IKBKG161 IRAK185 MIR71854 DUSP952 F846 H2AB143 NSDHL35 G6PD33 FLNA28 IDH3G26 (54 more . . .) MPP11 MIR2241 MIR105-11 MAGEA111 Xq28 (b) OMIM: 312750 Names: Rett syndrome; RTT; RTS autism, dementia, ataxia, and loss of purposeful hand use \u2013same as above\u2013 Chromosome Y deletions Yq11 OMIM: 415000 Names: Spermatogenic failure, Y-linked, 2; SPGFY2; Sertoli-cell-only syndrome; Del Castillo syn- drome; germ cell aplasia, spermatogenic failure {VN2}: RPS4Y225 UTY4 NLGN4Y4 KDM5D3 CD24P43 TMSB4Y1 (Implicated Genes from Microarray Studies) (GK, DMD, NR0B1) \u2020\u2021 (ABCD1, BCAP31, SLC6A8) \u2020\u2021 (MECP2) \u2020\u2021 (USP9Y, BPY2, CDY1) \u2020\u2021 Reported Effects on Speech Delayed speech [63] Delayed speech [64] Normal to absent speech Normal speech Sources: \u2020: [77], \u2021: [78], \u2020\u2021: From OMIM records, (cid:63): [32], \u2217\u2217: [50]. References 1. 2. 3. Singh, R. Pro\ufb01ling Humans from Their Voice; Springer-Nature: Singapore, 2019. Sataloff, R.T. Genetics of the voice. J. Voice 1995, 9, 16\u201319. [CrossRef] [PubMed] Ganapathiraju, M.K.; Thahir, M.; Handen, A.; Sarkar, S.N.; Sweet, R.A.; Nimgaonkar, V.L.;"}